Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,851 | 35,952 | 48,750 | 34,395 | 40,182 |
| TOTAL | $8,458 | $36,714 | $51,518 | $38,085 | $40,986 |
| Non-Current Assets | |||||
| PPE Net | 13,916 | 13,863 | 12,330 | 12,318 | 12,046 |
| Other Non-Current Assets | 18 | 18 | 18 | 18 | 1,794 |
| TOTAL | $13,934 | $13,881 | $12,348 | $12,336 | $13,840 |
| Total Assets | $22,392 | $50,595 | $63,866 | $50,421 | $54,826 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 875 | 13,391 | 7,154 | 4,723 | 7,634 |
| Accrued Expenses | 1,343 | 852 | 3,644 | 2,653 | 1,062 |
| Other current liabilities | N/A | 29 | 172 | 406 | 296 |
| TOTAL | $2,218 | $14,272 | $10,970 | $7,782 | $8,992 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 10,607 | 12,896 | 9,828 |
| TOTAL | $N/A | $N/A | $10,607 | $12,896 | $9,828 |
| Total Liabilities | $2,218 | $14,272 | $21,577 | $20,678 | $18,820 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22 | 17 | 14 | 14 | 11 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -241,551 | -221,772 | -193,468 | -164,727 | -134,392 |
| TOTAL | $20,174 | $36,323 | $42,289 | $29,743 | $36,006 |
| Total Liabilities And Equity | $22,392 | $50,595 | $63,866 | $50,421 | $54,826 |